A citation-based method for searching scientific literature


List of co-cited articles
253 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tay-Sachs screening: social and psychological impact.
B Childs, L Gordis, M M Kaback, H H Kazazian. Am J Hum Genet 1976
52
23


Effects of genetic screening on perceptions of health: a pilot study.
T M Marteau, M van Duijn, I Ellis. J Med Genet 1992
68
17

Psychological and social consequences of community carrier screening programme for cystic fibrosis.
E K Watson, E S Mayall, J Lamb, J Chapple, R Williamson. Lancet 1992
87
14

Genetic discrimination: perspectives of consumers.
E V Lapham, C Kozma, J O Weiss. Science 1996
195
14


Discrimination as a consequence of genetic testing.
P R Billings, M A Kohn, M de Cuevas, J Beckwith, J S Alper, M R Natowicz. Am J Hum Genet 1992
318
12

Population screening for cystic fibrosis: knowledge and emotional consequences 18 months later.
Claire Gordon, Ian Walpole, Stephen R Zubrick, Carol Bower. Am J Med Genet A 2003
26
23

Uptake of cystic fibrosis testing in primary care: supply push or demand pull?
H Bekker, M Modell, G Denniss, A Silver, C Mathew, M Bobrow, T Marteau. BMJ 1993
144
12



Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization.
E S Tambor, B A Bernhardt, G A Chase, R R Faden, G Geller, K J Hofman, N A Holtzman. Am J Hum Genet 1994
133
10

Genetic counseling: a consumers' view.
C O Leonard, G A Chase, B Childs. N Engl J Med 1972
182
10

A stigmatizing effect of the carrier status for cystic fibrosis?
G Evers-Kiebooms, L Denayer, M Welkenhuysen, J J Cassiman, H Van den Berghe. Clin Genet 1994
36
13



Outcome of a school screening programme for carriers of haemoglobin disease.
D Lena-Russo, C Badens, M Aubinaud, F Merono, C Paolasso, N Martini, J F Mattei. J Med Screen 2002
28
17

Screening for carriers of cystic fibrosis through primary health care services.
E K Watson, E Mayall, J Chapple, M Dalziel, K Harrington, C Williams, R Williamson. BMJ 1991
115
10


Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. The South Wales Cystic Fibrosis Carrier Screening Research Team.
Y Payne, M Williams, J Cheadle, N C Stott, M Rowlands, D Shickle, G West, L Meredith, M Goodchild, P S Harper,[...]. Clin Genet 1997
38
13

Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction.
L Henneman, I Bramsen, H M van der Ploeg, L P ten Kate. Genet Test 2002
35
14


Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners.
M E Mennie, M E Compton, A Gilfillan, W A Liston, I Pullen, D A Whyte, D J Brock. J Med Genet 1993
52
8




Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening.
E W Clayton, V L Hannig, J P Pfotenhauer, R A Parker, P W Campbell, J A Phillips. Am J Hum Genet 1996
71
8

The impact of population based screening for carriers of cystic fibrosis.
H Bekker, G Denniss, M Modell, M Bobrow, T Marteau. J Med Genet 1994
70
8


Population screening for cystic fibrosis in Western Australia: community response.
M Honnor, S R Zubrick, I Walpole, C Bower, J Goldblatt. Am J Med Genet 2000
38
10




Predictive testing for Huntington's disease with use of a linked DNA marker.
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
153
6

Social perspectives in Huntington's chorea.
M R Hayden, R Ehrlich, H Parker, S J Ferera. S Afr Med J 1980
46
6


Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
181
6


Increased rate of suicide among patients with Huntington's disease.
M Schoenfeld, R H Myers, L A Cupples, B Berkman, D S Sax, E Clark. J Neurol Neurosurg Psychiatry 1984
157
6


Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1)
E S Cohn, P M Kelley, T W Fowler, M P Gorga, D M Lefkowitz, H J Kuehn, G B Schaefer, L S Gobar, F J Hahn, D J Harris,[...]. Pediatrics 1999
154
6

Attitudes of deaf adults toward genetic testing for hereditary deafness.
A Middleton, J Hewison, R F Mueller. Am J Hum Genet 1998
95
6

Parental attitudes toward genetic testing for pediatric deafness.
J W Brunger, G S Murray, M O'Riordan, A L Matthews, R J Smith, N H Robin. Am J Hum Genet 2000
87
6


Carrier testing in the fragile X syndrome: attitudes and opinions of obligate carriers.
A McConkie-Rosell, G A Spiridigliozzi, T Iafolla, J Tarleton, A M Lachiewicz. Am J Med Genet 1997
45
6


Genetic discrimination and the law.
M R Natowicz, J K Alper, J S Alper. Am J Hum Genet 1992
83
6


A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.
K Barlow-Stewart, L Burnett, A Proos, V Howell, F Huq, R Lazarus, H Aizenberg. J Med Genet 2003
48
6

Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong -- implications for population screening.
Y L Lau, L C Chan, Y Y Chan, S Y Ha, C Y Yeung, J S Waye, D H Chui. N Engl J Med 1997
164
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.